| NK cell metabolism and tumor microenvironment I Terrén, A Orrantia, J Vitallé, O Zenarruzabeitia, F Borrego Frontiers in Immunology 10, 483200, 2019 | 327 | 2019 |
| Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection A Pérez-Gómez, J Vitallé, C Gasca-Capote, A Gutierrez-Valencia, ... Cellular & Molecular Immunology 18 (9), 2128-2139, 2021 | 89 | 2021 |
| The biology and disease relevance of CD300a, an inhibitory receptor for phosphatidylserine and phosphatidylethanolamine O Zenarruzabeitia, J Vitallé, C Eguizabal, VR Simhadri, F Borrego The Journal of Immunology 194 (11), 5053-5060, 2015 | 80 | 2015 |
| Implication of interleukin-12/15/18 and ruxolitinib in the phenotype, proliferation, and polyfunctionality of human cytokine-preactivated natural killer cells I Terrén, I Mikelez, I Odriozola, A Gredilla, J González, A Orrantia, J Vitallé, ... Frontiers in Immunology 9, 737, 2018 | 53 | 2018 |
| Metabolic changes of Interleukin-12/15/18-stimulated human NK cells I Terrén, A Orrantia, A Mosteiro, J Vitallé, O Zenarruzabeitia, F Borrego Scientific Reports 11 (1), 6472, 2021 | 45 | 2021 |
| CD300 receptor family in viral infections J Vitallé, I Terrén, A Orrantia, O Zenarruzabeitia, F Borrego European journal of immunology 49 (3), 364-374, 2019 | 42 | 2019 |
| The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults O Zenarruzabeitia, J Vitallé, S García-Obregón, I Astigarraga, C Eguizabal, ... Scientific reports 6 (1), 32693, 2016 | 36 | 2016 |
| NK cell-based immunotherapy in renal cell carcinoma I Terrén, A Orrantia, I Mikelez-Alonso, J Vitallé, O Zenarruzabeitia, ... Cancers 12 (2), 316, 2020 | 28 | 2020 |
| CFSE dilution to study human T and NK cell proliferation in vitro I Terrén, A Orrantia, J Vitallé, O Zenarruzabeitia, F Borrego Methods in Enzymology 631, 239-255, 2020 | 27 | 2020 |
| Modulating NK cell metabolism for cancer immunotherapy I Terrén, A Orrantia, J Vitallé, G Astarloa-Pando, O Zenarruzabeitia, ... Seminars in Hematology 57 (4), 213-224, 2020 | 26 | 2020 |
| The expression and function of CD300 molecules in the main players of allergic responses: mast cells, basophils and eosinophils J Vitallé, I Terrén, A Orrantia, A Bilbao, PM Gamboa, F Borrego, ... International journal of molecular sciences 21 (9), 3173, 2020 | 24 | 2020 |
| CD300c costimulates IgE-mediated basophil activation, and its expression is increased in patients with cow's milk allergy O Zenarruzabeitia, J Vitallé, I Terrén, A Orrantia, I Astigarraga, L Dopazo, ... Journal of Allergy and Clinical Immunology 143 (2), 700-711. e5, 2019 | 21 | 2019 |
| CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients J Vitallé, I Terrén, A Orrantia, R Pérez-Garay, F Vidal, JA Iribarren, ... Cellular & Molecular Immunology 16 (12), 940-942, 2019 | 19 | 2019 |
| A NKp80-based identification strategy reveals that CD56neg NK cells are not completely dysfunctional in health and disease A Orrantia, I Terrén, A Izquierdo-Lafuente, JA Alonso-Cabrera, V Sandá, ... Iscience 23 (7), 2020 | 15 | 2020 |
| SARS-CoV-2 evolution and spike-specific CD4+ T-cell response in persistent COVID-19 with severe HIV immune suppression H Álvarez, E Ruiz-Mateos, PM Juiz-González, J Vitallé, I Viéitez, ... Microorganisms 10 (1), 143, 2022 | 13 | 2022 |
| Monocytes phenotype and cytokine production in human immunodeficiency virus-1 infected patients receiving a modified vaccinia ankara-based HIV-1 vaccine: relationship to CD300 … J Vitallé, O Zenarruzabeitia, I Terrén, M Plana, AC Guardo, L Leal, J Peña, ... Frontiers in Immunology 8, 836, 2017 | 13 | 2017 |
| Natural killer cells to the attack: combination therapy against neuroblastoma O Zenarruzabeitia, J Vitallé, I Astigarraga, F Borrego Clinical Cancer Research 23 (3), 615-617, 2017 | 13 | 2017 |
| Altered expression of CD300a inhibitory receptor on CD4+ T cells from human immunodeficiency virus-1-infected patients: association with disease progression markers J Vitallé, I Terrén, L Gamboa-Urquijo, A Orrantia, L Tarancón-Díez, ... Frontiers in immunology 9, 1709, 2018 | 12 | 2018 |
| Deciphering the quality of SARS‐CoV‐2 specific T‐cell response associated with disease severity, immune memory and heterologous response A Pérez‐Gómez, C Gasca‐Capote, J Vitallé, FJ Ostos, A Serna‐Gallego, ... Clinical and translational medicine 12 (4), e802, 2022 | 11 | 2022 |
| Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in aged people J Vitallé, A Pérez-Gómez, FJ Ostos, C Gasca-Capote, MR Jiménez-León, ... JCI insight 7 (17), 2022 | 10 | 2022 |
